Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting

• Status: Unknown status
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will determine if giving Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)orally will be effective as a prophylactic anti-emetic drug for patients who underwent arthroscopic rotator cuff repair under general anesthesia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: CM Chungmu Hospital
• Collaborator: Korea United Pharm. Inc.
• Treatments: Antiemetics; Bromazepam; Maleic acid; Medazepam; Metoclopramide; Mosapride; Simethicone; Trimebutine

Criteria

Inclusion Criteria:

• post arthroscopic cuff repair patient previously diagnosed with small to large rotator cuff tear thru MRI

Exclusion Criteria:

• above 70 years old

• massive rotator cuff tear